Stock SLN SILENCE THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Silence Therapeutics plc

Equities

SLN

US82686Q1013

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
23 USD +0.26% Intraday chart for Silence Therapeutics plc +8.44% +32.41%
05-17 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading MT
05-16 European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading
MT
Silence Therapeutics : Condensed consolidated income statement (unaudited) - Form 6-K
PU
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
BU
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher
MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
BU
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
BU
Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024
CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT
Silence Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K
PU
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
MT
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
BU
Silence Therapeutics plc Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLN Stock
  4. News Silence Therapeutics plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW